William Ganz
William Ganz (1919–2009), Slovakian-born cardiologist, co-invented the Swan-Ganz catheter and pioneered thermodilution in cardiovascular research
Tag Thrombolysis
Wake up Thrombolysis
Why keep fighting? 15 million strokes/year (WHO) >5 million permanently disabled >500,000 deaths Wake-up Strokes >20-25% occur during bedtime hours
Bedside Echo in Pulmonary Embolism
A 35 year-old female is brought to the emergency department after collapsing in a shopping centre. McConnell sign
Thrombolysis for submassive pulmonary embolus
The use of thrombolytics for the treatment of submassive PE is controversial — the limited documented benefit (e.g. improved hemodynamics, potential for less chronic pulmonary hypertension) must be weighed against the increased risk of life-threatening hemorrhage and the availability of other therapies (e.g. catheter-directed thrombolysis or clot retrieval)
Alteplase (rtPA)
Alteplase is a tissue plasminogen activator used as a thrombolytic medication in: Acute Ischaemic Strokes, Acute Myocardial Infarction and PE
Stroke Thrombolysis
Stroke Thrombolysis: thrombolysis for acute ischaemic stroke is a controversial intervention; it is supported by a number of guidelines and in general is viewed favourably by the neurological community
Tenecteplase (TNK-tPA)
Tenecteplase is a tissue plasminogen activator used as a thrombolytic medication in: Acute Ischaemic Strokes, Acute Myocardial Infarction, PE
STEMI Management
STEMI is a type of acute coronary syndrome that requires emergency reperfusion therapy. Definition and assessment of STEMI is described in Acute Coronary Syndromes
Acute Coronary Syndromes Literature Summaries
Acute Coronary Syndromes (ACS) Literature Summaries
Schrödinger’s Fence
Schrödinger’s Fence...or, where we currently sit on the matter of thrombolysis in Acute Stroke. An Opinion Piece on IST-3
The Use of Thrombolysis as a Treatment for Acute Stroke
Do we, as a global medical profession, truly know whether or not tPA is a beneficial treatment early on in the presentation of a CVA?
Why we should be very wary of using clotbusting drugs to treat acute strokes
This is Part 1 of three posts a basic overview of thrombolysis in stroke a detailed overview of evidence based research into thrombolysis and CVA Schrödinger’s Fence Author: Prof Daniel Fatovich Let’s compare the treatment of strokes, to the treatment of…